News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
763,630 Results
Type
Article (45870)
Company Profile (328)
Press Release (717404)
Multimedia
Podcasts (163)
Webinars (30)
Section
Business (215363)
Career Advice (2169)
Deals (37410)
Drug Delivery (149)
Drug Development (84359)
Employer Resources (178)
FDA (17136)
Job Trends (15846)
News (363601)
Policy (34575)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2749)
Accelerated approval (48)
Adcomms (30)
Allergies (179)
Alliances (53672)
ALS (219)
Alzheimer's disease (1859)
Antibody-drug conjugate (ADC) (479)
Approvals (17492)
Artificial intelligence (726)
Autoimmune disease (302)
Automation (60)
Bankruptcy (378)
Best Places to Work (12025)
BIOSECURE Act (21)
Biosimilars (233)
Biotechnology (198)
Bladder cancer (190)
Brain cancer (77)
Breast cancer (769)
Cancer (5985)
Cardiovascular disease (495)
Career advice (1842)
Career pathing (44)
CAR-T (346)
CDC (62)
Celiac Disease (3)
Cell therapy (952)
Cervical cancer (47)
Clinical research (72994)
Collaboration (2226)
Company closure (5)
Compensation (1401)
Complete response letters (89)
COVID-19 (2869)
CRISPR (118)
C-suite (1176)
Cystic fibrosis (160)
Data (7945)
Decentralized trials (3)
Denatured (65)
Depression (175)
Dermatology (87)
Diabetes (596)
Diagnostics (7140)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (347)
Drug pricing (228)
Drug shortages (34)
Duchenne muscular dystrophy (290)
Earnings (94401)
Editorial (70)
Employer branding (21)
Employer resources (158)
Events (124856)
Executive appointments (1132)
FDA (20916)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1799)
Gene editing (249)
Generative AI (66)
Gene therapy (770)
GLP-1 (1136)
Government (4986)
Grass and pollen (7)
Guidances (410)
Healthcare (19692)
HIV (82)
Huntington's disease (57)
IgA nephropathy (99)
Immunology and inflammation (322)
Immuno-oncology (99)
Indications (192)
Infectious disease (3219)
Inflammatory bowel disease (229)
Inflation Reduction Act (16)
Influenza (140)
Intellectual property (296)
Interviews (341)
IPO (17124)
IRA (59)
Job creations (4133)
Job search strategy (1532)
JPM (69)
Kidney cancer (20)
Labor market (102)
Layoffs (607)
Leadership (43)
Legal (8524)
Liver cancer (103)
Longevity (34)
Lung cancer (783)
Lymphoma (433)
Machine learning (63)
Management (61)
Manufacturing (1106)
MASH (198)
Medical device (14271)
Medtech (14396)
Mergers & acquisitions (21515)
Metabolic disorders (1569)
mRNA (234)
Multiple sclerosis (190)
NASH (20)
Neurodegenerative disease (440)
Neuropsychiatric disorders (117)
Neuroscience (3433)
Neurotech (1)
NextGen: Class of 2026 (6925)
Non-profit (4775)
Now hiring (78)
Obesity (745)
Opinion (325)
Ovarian cancer (225)
Pain (270)
Pancreatic cancer (306)
Parkinson's disease (368)
Partnered (38)
Patents (607)
Patient recruitment (681)
Peanut (66)
People (62643)
Pharmaceutical (89)
Pharmacy benefit managers (34)
Phase 1 (22690)
Phase 2 (32122)
Phase 3 (24032)
Pipeline (8843)
Policy (349)
Postmarket research (2668)
Preclinical (9684)
Press Release (68)
Prostate cancer (303)
Psychedelics (59)
Radiopharmaceuticals (336)
Rare diseases (1137)
Real estate (6473)
Recruiting (73)
Regulatory (26597)
Reports (57)
Research institute (2563)
Resumes & cover letters (371)
Rett syndrome (39)
RNA editing (25)
RSV (92)
Schizophrenia (188)
Series A (311)
Series B (223)
Service/supplier (12)
Sickle cell disease (117)
Special edition (26)
Spinal muscular atrophy (172)
Sponsored (51)
Startups (3950)
State (2)
Stomach cancer (20)
Supply chain (131)
Tariffs (100)
The Weekly (95)
Vaccines (1161)
Venture capital (120)
Weight loss (496)
Women's health (129)
Worklife (20)
Date
Last 7 days (868)
Last 30 days (3518)
Last 365 days (31029)
2026 (12828)
2025 (31242)
2024 (36297)
2023 (41210)
2022 (52459)
2021 (57005)
2020 (55648)
2019 (48607)
2018 (36728)
2017 (33762)
2016 (33349)
2015 (39354)
2014 (33114)
2013 (28151)
2012 (30189)
2011 (30943)
2010 (28910)
Location
Africa (832)
Alabama (99)
Alaska (7)
Arizona (359)
Arkansas (16)
Asia (43689)
Australia (7036)
California (13439)
Canada (3809)
China (1399)
Colorado (576)
Connecticut (585)
Delaware (409)
Europe (95003)
Florida (2005)
Georgia (433)
Hawaii (3)
Idaho (67)
Illinois (1084)
India (95)
Indiana (617)
Iowa (24)
Japan (550)
Kansas (134)
Kentucky (52)
Louisiana (43)
Maine (89)
Maryland (1616)
Massachusetts (9665)
Michigan (368)
Minnesota (731)
Mississippi (7)
Missouri (148)
Montana (34)
Nebraska (29)
Nevada (147)
New Hampshire (87)
New Jersey (3512)
New Mexico (31)
New York (3524)
North Carolina (1772)
North Dakota (11)
Northern California (6714)
Ohio (407)
Oklahoma (25)
Oregon (46)
Pennsylvania (2702)
Puerto Rico (29)
Rhode Island (50)
South America (1211)
South Carolina (87)
South Dakota (2)
Southern California (5302)
Tennessee (215)
Texas (2169)
United States (47698)
Utah (400)
Vermont (1)
Virginia (346)
Washington D.C. (81)
Washington State (1097)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
763,630 Results for "catalyst pharmaceutical partners inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
Catalyst Pharmaceuticals comes with a trio of approved drugs as Angelini Pharma expands its neuroscience offerings.
May 7, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results
May 11, 2026
·
10 min read
Press Releases
Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast
May 8, 2026
·
2 min read
Press Releases
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
April 28, 2026
·
2 min read
Press Releases
PharmaTher’s Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides
U.S. regulatory momentum in psychedelics and peptides could open new commercial opportunities for PharmaTher’s PatchPrint™ automated manufacturing platform and PharmaPatch™ product platform as an attractive solution for compounding pharmacies, hospitals, research institutions, and commercial partners
April 20, 2026
·
8 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
February 24, 2026
·
2 min read
Press Releases
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
May 7, 2026
·
5 min read
Press Releases
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
January 5, 2026
·
2 min read
Press Releases
Catalyst MedTech Announces Acquisition of X3D
April 2, 2026
·
3 min read
Press Releases
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
February 11, 2026
·
2 min read
1 of 76,363
Next
